{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T18:02:39Z","timestamp":1771524159537,"version":"3.50.1"},"reference-count":52,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T00:00:00Z","timestamp":1294099200000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis C is a common cause of chronic viral infection of the liver. It is associated with insulin resistance and the development of type 2 diabetes mellitus. It is also associated with the development of hepatic steatosis. The presence of hepatic steatosis is associated with an increased risk of having hepatic fibrosis. This is also associated with the severity of insulin resistance. These findings are specifically germane for those with genotype1 infection. Genotype 3 infection independently causes steatosis and successful treatment of the virus is followed by resolution of steatosis. In genotype 1 infection, the presence of hepatic steatosis is also a risk factor for failure to respond to pegylated interferon and ribavirin therapy. Unfortunately efforts to treat insulin resistance prior to antiviral therapy have not been very successful. Newer efforts focused on the role of specific micro RNAs in mediating the metabolic effects of hepatitis C virus infection may provide to ameliorate the metabolic risks of HCV infection.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2010.02397.x","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T15:16:48Z","timestamp":1294154208000},"page":"23-28","source":"Crossref","is-referenced-by-count":28,"title":["Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C"],"prefix":"10.1111","volume":"31","author":[{"given":"Arun J.","family":"Sanyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,4]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/bega.1999.0071"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2001.021004266.x"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"e_1_2_9_5_2","first-page":"1636","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C","volume":"130","author":"Leandro G","year":"2006","journal-title":"a meta-analysis of individual patient data"},{"key":"e_1_2_9_6_2","first-page":"123","article-title":"Steatosis in chronic hepatitis C","volume":"55","author":"Asselah T","year":"2006","journal-title":"why does it really matter?"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07640.x"},{"key":"e_1_2_9_8_2","first-page":"416","article-title":"Insulin resistance in chronic hepatitis C","volume":"134","author":"Moucari R","year":"2008","journal-title":"association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis"},{"key":"e_1_2_9_9_2","first-page":"390","article-title":"Liver fibrosis in women with chronic hepatitis C","volume":"56","author":"Codes L","year":"2007","journal-title":"evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy"},{"key":"e_1_2_9_10_2","first-page":"1183","article-title":"Nonalcoholic steatohepatitis","volume":"120","author":"Sanyal AJ","year":"2001","journal-title":"association of insulin resistance and mitochondrial abnormalities"},{"key":"e_1_2_9_11_2","first-page":"1648","article-title":"Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease","volume":"44","author":"Bugianesi E","year":"2006","journal-title":"Role of insulin resistance and hepatic steatosis"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23031"},{"issue":"1","key":"e_1_2_9_13_2","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S1665-2681(19)31829-0","article-title":"Insulin resistance and steatosis in chronic hepatitis C","volume":"8","author":"Machado MV","year":"2009","journal-title":"Ann Hepatol"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1995.tb00466.x"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-004-0022-5"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.08.032"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.11.1638"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23859"},{"issue":"1","key":"e_1_2_9_19_2","first-page":"694","article-title":"Disrupted signaling and inhibited regeneration in obese mice with fatty livers","volume":"34","author":"Yang SQ","year":"2001","journal-title":"implications for nonalcoholic fatty liver disease pathophysiology"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23322"},{"key":"e_1_2_9_21_2","first-page":"465","article-title":"Diabetes mellitus","volume":"8","author":"Gao C","year":"2009","journal-title":"a \u2018true\u2019 independent risk factor for hepatocellular carcinoma?"},{"key":"e_1_2_9_22_2","first-page":"2183","article-title":"Population\u2010based risk factors and resource utilization for HCC","volume":"26","author":"Sanyal A","journal-title":"US perspective"},{"key":"e_1_2_9_23_2","first-page":"2127","article-title":"Hepatitis C virus infection","volume":"47","author":"Sheikh MY","year":"2008","journal-title":"molecular pathways to metabolic syndrome"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80166-X"},{"issue":"2","key":"e_1_2_9_25_2","first-page":"cclxix","article-title":"The role of serum leptin levels in chronic hepatitis C with steatosis","volume":"50","author":"Ellidokuz E","year":"2003","journal-title":"Hepato-gastroenterology"},{"key":"e_1_2_9_26_2","first-page":"586","article-title":"Steatosis and hepatitis C virus","volume":"126","author":"Lonardo A","year":"2004","journal-title":"mechanisms and significance for hepatic and extrahepatic disease"},{"key":"e_1_2_9_27_2","first-page":"729","article-title":"Steatosis in chronic hepatitis C","volume":"36","author":"Monto A","year":"2002","journal-title":"relative contributions of obesity, diabetes mellitus, and alcohol"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.018770"},{"key":"e_1_2_9_29_2","first-page":"420","article-title":"Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C","volume":"53","author":"Castera L","year":"2004","journal-title":"indirect evidence of a role of hepatitis C virus genotype 3 in steatosis"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2004.00528.x"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2003.11.004"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01025.x"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.026393"},{"key":"e_1_2_9_34_2","first-page":"840","article-title":"Hepatitis C virus infection and diabetes","volume":"126","author":"Shintani Y","year":"2004","journal-title":"direct involvement of the virus in the development of insulin resistance"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.5.1102"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300429"},{"key":"e_1_2_9_37_2","first-page":"1384","article-title":"Impaired IRS\u20101\/PI3\u2010kinase signaling in patients with HCV","volume":"38","author":"Aytug S","year":"2003","journal-title":"a mechanism for increased prevalence of type 2 diabetes"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.22.12766"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2001.1225"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp553"},{"key":"e_1_2_9_41_2","unstructured":"CheungO SanyalAJ.Role of microRNAs in Non\u2010Alcoholic Steatohepatitis: Curr Pharm Des (in press)."},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2008.244"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.12.049"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50350"},{"key":"e_1_2_9_45_2","first-page":"432","article-title":"Steatosis in chronic hepatitis C","volume":"35","author":"Giannini E","year":"2001","journal-title":"can weight reduction improve therapeutic efficacy?"},{"key":"e_1_2_9_46_2","first-page":"268","article-title":"Obesity predisposes to increased drainage following axillary node clearance","volume":"83","author":"Banerjee D","year":"2001","journal-title":"a prospective audit"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.069674"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199903)57:3<223::AID-JMV2>3.0.CO;2-4"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198108273050909"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21232"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2237238100"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409834102"},{"key":"e_1_2_9_53_2","first-page":"895","article-title":"Atorvastatin does not exhibit antiviral activity against HCV at conventional doses","volume":"45","author":"O'Leary JG","year":"2007","journal-title":"a pilot clinical trial"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2010.02397.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2010.02397.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T07:53:07Z","timestamp":1694591587000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2010.02397.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":52,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1478-3231.2010.02397.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02397.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}